Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus

作者: Lawrence Kleinberg , Malcolm Brock , Michael Gibson

DOI: 10.1007/S11864-015-0352-6

关键词:

摘要: Opinion statement: Adenocarcinoma of the esophagus is increasing in incidence Western nations leading to increased interest and opportunity study optimal management. Randomized trials have now robustly demonstrated preoperative therapy with chemoradiotherapy chemotherapy alone improves survival outcome for bulk curable patients, those locally advanced T1N1M0 T2-3 N0-1 M0 disease. Evidence suggests but does not confirm that radiation-containing regimens are more beneficial. Clinical staging designed exclude patients T1N0M0 disease who may be treated surgery metastatic benefit from intensive local therapy. The approach clinical includes endoscopy ultrasound fine needle aspirate assess regional disease, supplemented by CT PET scanning primarily Minimally invasive approaches esophagectomy used goal reducing complications, there no evidence mortality or ultimate improved.

参考文章(76)
Julia Cordin, Kuno Lehmann, Paul M. Schneider, Clinical Staging of Adenocarcinoma of the Esophagogastric Junction Recent results in cancer research. ,vol. 182, pp. 73- 83 ,(2009) , 10.1007/978-3-540-70579-6_6
K. Kumagai, I. Rouvelas, J. A. Tsai, D. Mariosa, F. Klevebro, M. Lindblad, W. Ye, L. Lundell, M. Nilsson, Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. British Journal of Surgery. ,vol. 101, pp. 321- 338 ,(2014) , 10.1002/BJS.9418
Tetsuro Nishihira, Katsu Hirayama, Shozo Mori, A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. American Journal of Surgery. ,vol. 175, pp. 47- 51 ,(1998) , 10.1016/S0002-9610(97)00227-4
Chin Hur, Melecia Miller, Chung Yin Kong, Emily C. Dowling, Kevin J. Nattinger, Michelle Dunn, Eric J. Feuer, Trends in esophageal adenocarcinoma incidence and mortality Cancer. ,vol. 119, pp. 1149- 1158 ,(2013) , 10.1002/CNCR.27834
Tadashi Nishimaki MD, Tsutomu Suzuki MD, Satoshi Suzuki MD,, Shirou Kuwabara MD, Katsuyoshi Hatakeyama MD, Outcomes of Extended Radical Esophagectomy for Thoracic Esophageal Cancer Journal of The American College of Surgeons. ,vol. 186, pp. 306- 312 ,(1998) , 10.1016/S1072-7515(98)00013-1
Surya S. A. Y. Biere, Miguel A. Cuesta, Mark I. van Berge Henegouwen, Donald L. van der Peet, Randomised trial, Minimally Invasive Oesophagectomy versus open oesophagectomy for patients with resectable oesophageal cancer Journal of Thoracic Disease. ,vol. 4, pp. 462- 464 ,(2012) , 10.3978/J.ISSN.2072-1439.2012.08.12
James D. Luketich, Arjun Pennathur, Omar Awais, Ryan M. Levy, Samuel Keeley, Manisha Shende, Neil A. Christie, Benny Weksler, Rodney J. Landreneau, Ghulam Abbas, Matthew J. Schuchert, Katie S. Nason, Outcomes after minimally invasive esophagectomy: review of over 1000 patients Annals of Surgery. ,vol. 256, pp. 95- 103 ,(2012) , 10.1097/SLA.0B013E3182590603
David H. Ilson, Bruce D. Minsky, Geoffrey Y. Ku, Valerie Rusch, Nabil Rizk, Manish Shah, David P. Kelsen, Marinela Capanu, Laura Tang, Jenny Campbell, Manjit Bains, Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer. Cancer. ,vol. 118, pp. 2820- 2827 ,(2012) , 10.1002/CNCR.26591
M. Polkowski, Endosonographic staging of upper intestinal malignancy Best Practice & Research Clinical Gastroenterology. ,vol. 23, pp. 649- 661 ,(2009) , 10.1016/J.BPG.2009.05.002
Christian Jost, Janek Binek, Jan C. Schuller, Peter Bauerfeind, Urs Metzger, Baseli Werth, Juerg Knuchel, Jean-Louis Frossard, Philipp Bertschinger, Peter Brauchli, Christa Meyenberger, Thomas Ruhstaller, Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02) Gastrointestinal Endoscopy. ,vol. 71, pp. 1114- 1121 ,(2010) , 10.1016/J.GIE.2009.12.015